Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Montelukast sodium tablets (shunerning)

This product is suitable for the prevention and long-term treatment of asthma in adults aged 15 and over, including the prevention of daytime and nighttime asthma symptoms, the treatment of asthmatic patients sensitive to aspirin and the prevention of exercise-induced bronchoconstriction. This product is suitable for relieving the symptoms caused by allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults aged 15 and over). More role
App download minus 10 yuan
Common name:
Montelukast Sodium Tablets
Product No.:
B14202007317
Approval No.:
Gyzz j20130047 (inquired by the State Drug Administration)
Jianke price:
¥47.49
Product specification:
5mg*5s 4mg*5s 10mg*30s 0.5g: 4mg * 7 bags 4mg*30s 10mg*5s
Manufacturer:
Hangzhou moshadong Pharmaceutical Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
  • Product introduction
  • instructions
  • Qualification certificate
  • Relevant information
Product name Montelukast sodium tablets (shunerning)
Main raw materials The main component of this product is montelukast sodium.
Main role This product is suitable for the prevention and long-term treatment of asthma in adults aged 15 and over, including the prevention of daytime and nighttime asthma symptoms, the treatment of asthmatic patients sensitive to aspirin and the prevention of exercise-induced bronchoconstriction. This product is suitable for relieving the symptoms caused by allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults aged 15 and over).
Product specification 10mg*5s
Usage and dosage Take one tablet (10mg) once a day. Asthma patients should take it before going to bed. Patients with allergic rhinitis can take it when necessary according to their own conditions. Patients with asthma and allergic rhinitis should take medicine once a night. Adult patients aged 15 and over with asthma and / or allergic rhinitis were given 10mg once a day. General recommendations The therapeutic effect was evaluated by asthma control index. The curative effect of this product appeared within one day. This product can be taken with food or separately. Patients should be advised to take it consistently both during asthma control and deterioration. Elderly patients, patients with renal insufficiency, patients with mild to moderate liver damage and patients of different genders do not need to adjust the dose. Relationship between montelukast sodium tablets and other asthma drugs This product can be added to the patient's existing treatment plan. Reduce the combined dose: Bronchodilator For asthmatic patients who cannot be effectively controlled by bronchodilator alone, this product can be added to the treatment plan. Once there is obvious clinical efficacy response (generally after the first dose), the dose of bronchodilator can be reduced according to the patient's tolerance. Inhaled glucocorticoids After adding this product to asthmatic patients treated with inhaled glucocorticoids, the dose of glucocorticoids can be appropriately reduced according to the patient's tolerance. It should be gradually reduced under the guidance of doctors. Some patients can gradually reduce the dose until inhaled glucocorticoids are completely stopped. However, this product should not be used to suddenly replace inhaled glucocorticoids.
manufacturing enterprise Hangzhou moshadong Pharmaceutical Co., Ltd
Jianke commitment
  • Genuine guarantee, formal invoice

    Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

  • Private packaging, privacy protection

    When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

  • Efficient logistics and safe arrival

    All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

  • Three warehouses to ensure inventory

    Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

[drug name] Montelukast sodium tablets (shunerning)

[common name] Montelukast Sodium Tablets

[specification and model] 10mg*5s

[manufacturer] Hangzhou moshadong Pharmaceutical Co., Ltd

[drug type] Western medicine

[approval No.] Gyzz j20130047

[validity period] 36 months

[functional indications] This product is suitable for the prevention and long-term treatment of asthma in adults aged 15 and over, including the prevention of daytime and nighttime asthma symptoms, the treatment of asthmatic patients sensitive to aspirin and the prevention of exercise-induced bronchoconstriction. This product is suitable for relieving the symptoms caused by allergic rhinitis (seasonal allergic rhinitis and perennial allergic rhinitis in adults aged 15 and over).

[usage and dosage] Take one tablet (10mg) once a day. Asthma patients should take it before going to bed. Patients with allergic rhinitis can take it when necessary according to their own conditions. Patients with asthma and allergic rhinitis should take medicine once a night. Adult patients aged 15 and over with asthma and / or allergic rhinitis were given 10mg once a day. General recommendations The therapeutic effect was evaluated by asthma control index. The curative effect of this product appeared within one day. This product can be taken with food or separately. Patients should be advised to take it consistently both during asthma control and deterioration. Elderly patients, patients with renal insufficiency, patients with mild to moderate liver damage and patients of different genders do not need to adjust the dose. Relationship between montelukast sodium tablets and other asthma drugs This product can be added to the patient's existing treatment plan. Reduce the combined dose: Bronchodilator For asthmatic patients who cannot be effectively controlled by bronchodilator alone, this product can be added to the treatment plan. Once there is obvious clinical efficacy response (generally after the first dose), the dose of bronchodilator can be reduced according to the patient's tolerance. Inhaled glucocorticoids After adding this product to asthmatic patients treated with inhaled glucocorticoids, the dose of glucocorticoids can be appropriately reduced according to the patient's tolerance. It should be gradually reduced under the guidance of doctors. Some patients can gradually reduce the dose until inhaled glucocorticoids are completely stopped. However, this product should not be used to suddenly replace inhaled glucocorticoids.

[adverse reactions] This product is generally well tolerated with mild adverse reactions, and usually does not need to terminate treatment. The overall adverse reaction rate of this product is similar to that of placebo. Asthma patients aged 15 and over A clinical study has been conducted in about 2600 adult asthmatic patients aged 15 and over to evaluate the safety of this product. In the two similar design, placebo-controlled 12 week clinical studies, the drug-related incidence ≥ 1% in the treatment group and higher than that in the placebo group were abdominal pain and headache. However, there was no significant difference in the incidence of these adverse events between the two groups. In the clinical study, 544 patients have been treated with this product for at least 6 months, 253 patients for 1 year and 21 patients for 2 years. The occurrence of adverse events did not change with the extension of treatment time. (see the inner packaging manual for details)

[precautions] The efficacy of oral administration of this product in the treatment of acute asthma attack has not been determined. Therefore, it should not be used in the treatment of acute asthma attack. Although the combined dose of inhaled glucocorticoids can be gradually reduced under the guidance of doctors, this product should not be used to suddenly replace inhaled or oral glucocorticoids. In patients treated with antiasthmatic drugs, including leukotriene receptor antagonists, when reducing the systemic dose of glucocorticoids, very few cases have one or more of the following conditions: eosinophilia, vascular rash, deterioration of pulmonary symptoms, cardiac complications and / or neuropathy (sometimes diagnosed as church Strauss syndrome - a systemic eosinophilic vasculitis). Although the causal relationship between these conditions and leukotriene receptor antagonists has not been determined, it is recommended that attention should be paid and appropriate clinical monitoring should be performed when patients treated with this product reduce the systemic glucocorticoid dose. Please read the instructions carefully and follow the doctor's instructions.

[taboo] It is forbidden for those who are allergic to any component of this product.

[listing Permit Holder] Hangzhou moshadong Pharmaceutical Co., Ltd

[packaging unit] box

[main ingredients] The main component of this product is montelukast sodium.

[character] This product is light yellow special-shaped film coated tablets.

[applicable population] adult

[medication for pregnant and lactating women] There is no research data on pregnant women. Unless it is clearly necessary to take medicine, pregnant women should avoid taking this product. Global post marketing experience shows that there are rare reports of neonatal congenital limb defects after using this product during pregnancy. Most of these women also use other asthma drugs during pregnancy. The causal relationship between the use of this product and these events has not been established. It is unknown Determine whether it can be secreted from milk. Since many drugs can be secreted from milk, lactating women should use this product with caution.

[medication for children] Safety and efficacy studies have been conducted in children aged 6 months to 14 years. For the medication of children aged 2 to 14 years, please refer to the [usage and dosage] of montelukast sodium chewable tablets. The safety and efficacy of children under 6 months have not been studied. Studies have shown that this product will not affect the growth rate of children.

[medication for elderly patients] In clinical studies, there was no age difference in the efficacy and safety of this product.

[storage] Store at room temperature of 15 ~ 30 ℃, moisture-proof and shading

Praise degree

zero%

    reminder

    Dear customer:

    In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

    Montelukast sodium tablets (shunerning)

    ¥47.49

    reminder

    To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

    Please enter the correct verification code!
    Loding...
    Can't see clearly. Change one

    Dear customer:

    Your callback failed this time. Please re-enter the verification code to try. Thank you!